Opal Therapeutics
Catalyzing drug discovery for women's health in endometriosis and fibroids
San Francisco, United States · Founded 2024 · $275K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- opaltherapeutics.com
- Total Funding
- $275K
- Last Round
- $275K GrantSep 2024
- Rounds
- 1
About
Opal Therapeutics is a women's health biotech company building high-fidelity, patient-derived uterine organoid models of endometriosis and fibroids. Their platform helps biotech and pharma companies accelerate drug discovery and de-risk development through compound screening and biomarker validation using human preclinical data.
Summary
Opal Therapeutics is a Femtech company based in San Francisco, United States, founded in 2024. It has raised $275K in total across 1 round, most recently a $275K Grant round in Sep 2024. Investors include National Science Foundation.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...